Literature DB >> 3476184

Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passage.

R Kunzmann, F Hölzel.   

Abstract

Cytogenetic analyses of the ovarian carcinoma line EFO-27 demonstrated a limited amount of chromosomal aberrations during long-term maintenance. Between passage 16 and 179 of the cultivation the karyotype shifted to a more homogeneous pattern of tetraploid cells, the occurrence of marker chromosomes mar1 [del(X)] and mar2 [t(X;2)], already present in low-passage cells, was stabilized and marker mar3 [del(9)] was added. After passage through the nude mouse, only near-tetraploid cells were preserved; mar1 to mar3 were abandoned and three additional marker chromosomes mar4 [t(4;9)], mar5 [t(8;9)], and mar6 [t(10;14)] were acquired. Marker 7, consisting of chromosome #16 with an amplified heterochromatic region was characteristically present in nearly all cells and passages of the cultivation. Pericentric variation of the heterochromatin position was found in chromosomes #9 with the exception of nude mouse tumor cells. Hetermorphism of chromosomes #9 and #16 appears to have a prominent role as structural aberration in EFO-27 cells. The results suggest the influence of in vitro and in vivo conditions acting as selection mechanisms concomitant with acquisition or loss of chromosomal markers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476184     DOI: 10.1016/0165-4608(87)90206-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  14 in total

1.  A new cell line from human undifferentiated carcinoma of the ovary: establishment and characterization.

Authors:  J W Kim; C G Lee; M S Lyu; H K Kim; J G Rha; D H Kim; S J Kim; S E Namkoong
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Detection of chromosome 11q23 involving translocations by pulsed field gel electrophoresis.

Authors:  J Finke; R Kunzmann; W Lange
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

3.  Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

Authors:  J J König; E Kamst; A Hagemeijer; J C Romijn; J Horoszewicz; F H Schröder
Journal:  Urol Res       Date:  1989

4.  BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.

Authors:  Britta Stordal; Kirsten Timms; Angela Farrelly; Danielle Gallagher; Steven Busschots; Mickaël Renaud; Julien Thery; Deborah Williams; Jennifer Potter; Thanh Tran; Greg Korpanty; Mattia Cremona; Mark Carey; Jie Li; Yang Li; Ozlem Aslan; John J O'Leary; Gordon B Mills; Bryan T Hennessy
Journal:  Mol Oncol       Date:  2013-01-31       Impact factor: 6.603

5.  Primary spinal malignant schwannoma: clinical, histological and cytogenetic findings.

Authors:  J M Valdueza; C Hagel; M Westphal; M Hänsel; H D Herrmann
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

6.  Production of insulin-like growth factor binding proteins by human ovarian carcinoma cells.

Authors:  J Hofmann; B Wegmann; R Hackenberg; R Kunzmann; K D Schulz; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

7.  Karyotype analyses of 20 human glioma cell lines.

Authors:  M Westphal; M Hänsel; W Hamel; R Kunzmann; F Hölzel
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.

Authors:  G Chenevix-Trench; J Kerr; M Friedlander; T Hurst; B Sanderson; M Coglan; B Ward; J Leary; S K Khoo
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

9.  Targeting SRC and tubulin in mucinous ovarian carcinoma.

Authors:  Tao Liu; Wei Hu; Heather J Dalton; Hyun Jin Choi; Jie Huang; Yu Kang; Sunila Pradeep; Takahito Miyake; Jian H Song; Yunfei Wen; Chunhua Lu; Chad V Pecot; Justin Bottsford-Miller; Behrouz Zand; Nicholas B Jennings; Cristina Ivan; Gary E Gallick; Keith A Baggerly; David G Hangauer; Robert L Coleman; Michael Frumovitz; Anil K Sood
Journal:  Clin Cancer Res       Date:  2013-10-07       Impact factor: 12.531

10.  Antiproliferative effects of interferon gamma in combination with alpha-difluoromethylornithine on human carcinoma cell cultures.

Authors:  M Klouche; H Kirchner; F Hölzel
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.